SGLT2 Inhibition, Visceral Adiposity, Weight, and Type 2 Diabetes Mellitus

Obesity (Silver Spring). 2020 Jul;28(7):1173. doi: 10.1002/oby.22864.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiposity
  • Diabetes Mellitus, Type 2*
  • Humans
  • Obesity, Abdominal*
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors